Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program

OBJECTIVE: Antidepressant medication use (ADM) has been shown to predict diabetes. This paper assessed the role of inflammatory markers in this relationship within the Diabetes Prevention Program (DPP). METHODS: DPP participants randomized to Metformin (MET), Lifestyle Intervention (ILS) or placebo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Psychosom Med
Auteurs principaux: de Groot, Mary, Marrero, David, Mele, Lisa, Doyle, Todd, Schwartz, Frank, Mather, Kieren J., Goldberg, Ronald, Price, David W., Ma, Yong, Knowler, William C.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5794527/
https://ncbi.nlm.nih.gov/pubmed/29016549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PSY.0000000000000535
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires